• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Assessment of immunity to influenza using artifical challenge of normal volunteers with influenza virus.

作者信息

Couch R B

出版信息

Dev Biol Stand. 1975;28:295-306.

PMID:1126573
Abstract

The candidate humoral mediators of protection against influenza include antibody (Ab) to the viral hemagglutinin (H) or neuraminidase (N) in serum or respiratory secretions. In the present studies these mediators were evaluated principally by low dose live virus challenge of previously vaccinated volunteers. Following IM vaccination with H3N2 virus, Ab appeared in both serum and secretions and direct quantitative relationship between the two was noted. Among individuals vaccinated intranasally with comparable doses, the serum and secretion Ab responses were similar to those after IM vaccination. Irrespective of immunization method, there was a better correlation between protection and titers of serum Ab than titers of Ab in nasal secretions. After vaccination with an N-specific vaccine, an inverse correlation between titer of serum anti-neuraminidase Ab and quantity of virus in secretions occurred. This was reflected in occurrence of illness in those with low Ab titers, infection only in those with intermediate Av titers and no evidence of infection in those with high Av titers. In a naturally occurring outbreak with the England variant, a similar pattern of infection responses occurred among persons with varying titers of serum anti-hemagglutinin Ab. This suggests that, in man, Ab to the H and to the N results in similar host responses to infection and that the extent of infection is determined by magnitude ofAb present.

摘要

相似文献

1
Assessment of immunity to influenza using artifical challenge of normal volunteers with influenza virus.
Dev Biol Stand. 1975;28:295-306.
2
Assessment of resistance to influenza virus infection in animal models.动物模型中流感病毒感染抗性的评估。
Dev Biol Stand. 1975;28:307-18.
3
Potency of influenza vaccines: mouse protection experiments in correlation to field studies in man.流感疫苗的效力:与人体现场研究相关的小鼠保护实验
Dev Biol Stand. 1975;28:336-9.
4
Neuraminidase antibody response to inactivated influenza virus vaccine following intranasal and intramuscular vaccination.鼻内接种和肌肉注射灭活流感病毒疫苗后的神经氨酸酶抗体反应。
Isr Med Assoc J. 2006 Mar;8(3):155-8.
5
Immune response to combined live influenza virus vaccines administered intranasally.对经鼻内接种的联合活流感病毒疫苗的免疫反应。
Dev Biol Stand. 1975;28:340-6.
6
[Clinical control, study of viral shedding and evaluation of circulating and local antibody response after administration of live and attenuated "Alice" strain influenza vaccine].[临床对照、接种减毒活“爱丽丝”株流感疫苗后病毒排出情况研究及循环抗体与局部抗体反应评估]
Boll Ist Sieroter Milan. 1976 Mar;55(71):1-12.
7
Beta 2-microglobulin-deficient mice can be protected against influenza A infection by vaccination with vaccinia-influenza recombinants expressing hemagglutinin and neuraminidase.通过接种表达血凝素和神经氨酸酶的痘苗-流感重组体疫苗,β2微球蛋白缺陷小鼠可免受甲型流感病毒感染。
J Immunol. 1993 Jun 15;150(12):5484-93.
8
The protection of ferrets against influenza by immunization with a split influenza vaccine.通过使用裂解流感疫苗免疫雪貂来预防流感。
Dev Biol Stand. 1975;28:167-72.
9
Protective immunity against influenza H5N1 virus challenge in mice by intranasal co-administration of baculovirus surface-displayed HA and recombinant CTB as an adjuvant.通过鼻内共同给予杆状病毒表面展示的血凝素(HA)和重组霍乱毒素B亚单位(CTB)作为佐剂,对小鼠进行针对H5N1流感病毒攻击的保护性免疫。
Virology. 2008 Oct 25;380(2):412-20. doi: 10.1016/j.virol.2008.08.002. Epub 2008 Sep 10.
10
Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans.交叉反应性神经氨酸酶抗体可为小鼠提供针对H5N1的部分保护,且在未接触过该病毒的人体内也存在。
PLoS Med. 2007 Feb;4(2):e59. doi: 10.1371/journal.pmed.0040059.

引用本文的文献

1
High-throughput neutralization measurements correlate strongly with evolutionary success of human influenza strains.高通量中和测量与人类流感毒株的进化成功密切相关。
bioRxiv. 2025 Mar 12:2025.03.04.641544. doi: 10.1101/2025.03.04.641544.
2
Mapping person-to-person variation in viral mutations that escape polyclonal serum targeting influenza hemagglutinin.绘制针对流感血凝素的多克隆血清靶向逃逸的病毒突变的个体间变异图谱。
Elife. 2019 Aug 27;8:e49324. doi: 10.7554/eLife.49324.
3
Seasonal influenza vaccination is the strongest correlate of cross-reactive antibody responses in migratory bird handlers.
季节性流感疫苗接种是候鸟处理人员交叉反应抗体反应的最强相关因素。
mBio. 2014 Dec 9;5(6):e02107. doi: 10.1128/mBio.02107-14.
4
Intranasal adenovirus-vectored vaccine for induction of long-lasting humoral immunity-mediated broad protection against influenza in mice.用于诱导持久体液免疫介导的对小鼠流感广泛保护的鼻内腺病毒载体疫苗。
J Virol. 2014 Sep 1;88(17):9693-703. doi: 10.1128/JVI.00823-14. Epub 2014 Jun 11.
5
Comparative analysis of hemagglutination inhibition titers generated using temporally matched serum and plasma samples.使用时间匹配的血清和血浆样本生成的血凝抑制滴度的比较分析。
PLoS One. 2012;7(12):e48229. doi: 10.1371/journal.pone.0048229. Epub 2012 Dec 20.
6
Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge.M2e 展示 T7 噬菌体纳米颗粒免疫可预防甲型流感病毒挑战。
PLoS One. 2012;7(9):e45765. doi: 10.1371/journal.pone.0045765. Epub 2012 Sep 24.
7
The human side of influenza.流感的人文视角。
J Leukoc Biol. 2012 Jul;92(1):83-96. doi: 10.1189/jlb.1011506. Epub 2012 Feb 23.
8
Influence of prior influenza vaccination on antibody and B-cell responses.既往流感疫苗接种对抗体和B细胞反应的影响。
PLoS One. 2008 Aug 20;3(8):e2975. doi: 10.1371/journal.pone.0002975.
9
Viruses and indoor air pollution.病毒与室内空气污染。
Bull N Y Acad Med. 1981 Dec;57(10):907-21.
10
Placebo-controlled double-blind clinical studies on the efficacy of different influenza vaccines assessed by experimental and natural infection.通过实验性感染和自然感染评估不同流感疫苗效力的安慰剂对照双盲临床研究。
Postgrad Med J. 1976 Jun;52(608):352-9. doi: 10.1136/pgmj.52.608.352.